Literature DB >> 11174025

Prognosis of renal amyloidosis: a clinicopathological study using cluster analysis.

Y Sasatomi1, Y Kiyoshi, N Uesugi, S Hisano, S Takebayashi.   

Abstract

Progression of renal amyloidosis is associated with severe proteinuria or nephrotic syndrome, and various mechanisms have been postulated to explain these complications. We studied the acceleration of proteinuria and reduced renal function by cluster analysis using clinical parameters, renal histological findings, type of renal amyloidosis and follow-up data. We divided 97 cases into three groups of renal amyloidosis. Accelerated progression correlated with serum creatinine (s-Cr) levels at renal biopsy and histological grade of renal damage by amyloid deposition (p < 0.0001). The most influential prognostic factors (s-Cr level > or =2.0 mg/dl) were tubulointerstitial and vascular damage induced by amyloid deposition at biopsy (odds ratio 96.9 and 69.2, respectively). In addition, we found amyloidosis type amyloid associated (AA) correlated with more amyloid-mediated vascular and tubulointerstitial damage than amyloidosis type amyloid light chain (AL) (p < 0.001, p < 0.01, respectively). Proteinuria and nephrotic syndrome were more severe in cases of amyloidosis AL than in amyloidosis AA (p = 0.076). In conclusion, less tubulointerstitial and vascular damage was caused by amyloid deposition; this was slowly progressive. Amyloid AA was detected in tubulointerstitial tissue and vessels more frequently than amyloid AL. Heavy proteinuria and/or nephrosis were not indicators of rapid progression. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11174025     DOI: 10.1159/000045883

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  10 in total

1.  Association between clinical characteristics and AL amyloid deposition in the kidney.

Authors:  Mitsuyo Itabashi; Takashi Takei; Misao Tsukada; Hidekazu Sugiura; Keiko Uchida; Ken Tsuchiya; Kazuho Honda; Kosaku Nitta
Journal:  Heart Vessels       Date:  2010-10-05       Impact factor: 2.037

2.  Chronic renal failure due to amyloid nephropathy caused by chronic infection after total hip replacement.

Authors:  Shinsuke Nishimura; Tomoji Matsumae; Yuji Murakami; Yasuhiro Abe; Yoshie Sasatomi; Ikufumi Nagayoshi; Kazuo Ueda; Hitoshi Nakashima
Journal:  CEN Case Rep       Date:  2014-04-16

3.  Prognostic value of histopathological scoring and grading in patients with renal AA amyloidosis.

Authors:  Arzu Ozdemir; Mürvet Yılmaz; Ayse Aysim Ozagari; Sibel Yucel Kocak
Journal:  Int Urol Nephrol       Date:  2022-03-11       Impact factor: 2.266

4.  Outcome of 121 patients with renal amyloid a amyloidosis.

Authors:  Elbis Ahbap; Ekrem Kara; Tuncay Sahutoglu; Taner Basturk; Yener Koc; Tamer Sakaci; Mustafa Sevinc; Cuneyt Akgol; Zuhal Atan Ucar; Arzu Ozdemir Kayalar; Feyza Bayraktar; Ayse Aysim Ozagari; Abdulkadir Unsal
Journal:  J Res Med Sci       Date:  2014-07       Impact factor: 1.852

5.  Clinical Presentation of Tubulointerstitial Nephritis Caused by Amyloid Light-chain Amyloidosis in a Patient with Sjögren's Syndrome.

Authors:  Reiko Inoue; Yoshihide Fujigaki; Kana Kobayashi; Yoshifuru Tamura; Tatsuru Ota; Shigeru Shibata; Tsuyoshi Ishida; Fukuo Kondo; Yutaka Yamaguchi; Shunya Uchida
Journal:  Intern Med       Date:  2017-02-15       Impact factor: 1.271

6.  A 16-year Survey of Clinicopathological Findings, Electron Microscopy, and Classification of Renal Amyloidosis.

Authors:  Seyed Mohammad Owji; Hadi Raeisi Shahraki; Seyed Hossein Owji
Journal:  Iran J Med Sci       Date:  2021-01

7.  Significant association between renal function and amyloid-positive area in renal biopsy specimens in AL amyloidosis.

Authors:  Takeshi Kuroda; Naohito Tanabe; Daisuke Kobayashi; Yoko Wada; Shuichi Murakami; Masaaki Nakano; Ichiei Narita
Journal:  BMC Nephrol       Date:  2012-09-24       Impact factor: 2.388

8.  Distribution of amyloid deposits in the kidneys of a patient with reactive amyloidosis associated with rheumatoid arthritis.

Authors:  Takeshi Kuroda; Naohito Tanabe; Hiroe Sato; Takeshi Nakatsue; Yoko Wada; Shuichi Murakami; Masaaki Nakano; Ichiei Narita
Journal:  BMC Res Notes       Date:  2013-06-14

9.  Revisiting renal amyloidosis with clinicopathological characteristics, grading, and scoring: A single-institutional experience.

Authors:  Abhiram Kalle; Archana Gudipati; Sree Bhushan Raju; Karthik Kalidindi; Swarnalatha Guditi; Gangadhar Taduri; Megha S Uppin
Journal:  J Lab Physicians       Date:  2018 Apr-Jun

Review 10.  CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond.

Authors:  Dario Roccatello; Roberta Fenoglio; Savino Sciascia; Carla Naretto; Daniela Rossi; Michela Ferro; Antonella Barreca; Fabio Malavasi; Simone Baldovino
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.